MediciNova Announces MN-166 (ibudilast) Demonstrated a 26% Reduction in Confirmed Disability Progression Biotech Investing
Precision Therapeutics, Formerly Skyline Medical, Announces Stock Ticker Symbol Change to AIPT Biotech Investing
Gemphire Announces Initiation of Phase 2a Clinical Trial of Gemcabene in Pediatric Non-Alcoholic Fatty Liver Disease Biotech Investing
Affimed Reports New Data for AFM13 from Two Separate Clinical Trials in Hodgkin and CD30-Positive Lymphomas Biotech Investing
